[1] C.A. Perez, L.V. Ackerman, W.B. Mill, J.H. Ogura and W.E. Powers. Cancer of the nasopharynx. Factors influencing prognosis, Cancer, 24(1) (1969) 1–17.
[2] J.D. Cox and K.K. Ang. Radiation Oncology E-Book: Rationale, Technique, Results, Elsevier Health Sciences, (2009).
[3] C.P. Titcomb. High incidence of nasopharyngeal carcinoma in Asia, Journal of Insurance Medicine-New York, 33(3) (2001) 235–238.
[4] A. Safavi-Naini, N. Raad, J. Ghorbani, S. Chaibakhsh and R. Ramezani-Daryasar. Incidence trends and geographical distribution of nasopharyngeal carcinoma in Iran, Iranian Journal of Cancer Prevention, 8(1) (2015) 24–28.
[5] B. Brennan. Nasopharyngeal carcinoma, Orphanet Journal of Rare Disease, 1(23) (2006) 1–5.
[6] A.T.C. Chan, P.M.L. Teo, T.W.T. Leung, S.F. Leung, W.Y. Lee, W. Yeo, P.H.K. Choi and P.J. Johnson. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma, International Journal of Radiation Oncology Biology Physics, 33(3) (1995) 569–577.
[7] G. Sanguineti, F.B. Geara, A.S. Garden, S.L. Tucker, K.K. Ang, W.H. Morrison and L.J. Peters. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control, International Journal of Radiation Oncology Biology Physics, 37(5) (1997) 985–996.
[8] P. Xia, K.K. Fu, G.W. Wong, C. Akazawa and L.J. Verhey. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma, International Journal of Radiation Oncology Biology Physics, 48(2) (2000) 329–337.
[9] N. Lee, P. Xia, J.M. Quivey, K. Sultanem, I. Poon, C. Akazawa, P. Akazawa, V. Weinberg and K.K. Fu. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. International Journal of Radiation Oncology Biology Physics, 53(1) (2002) 12–22.
[10] M.K.M. Kam, P.M.L. Teo, R.M.C. Chau, K.Y. Cheung, P.H.K. Choi, W.H. Kwan, S.F. Leung, B. Zee, and A.T.C. Chan. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience, International Journal of Radiation Oncology Biology Physics, 60(5) (2004) 1440–1450.
[11] L. Widesott, A. Pierelli, C. Fiorino, I. Dell'Oca, S. Broggi, G.M. Cattaneo, N. Di Muzio, F. Fazio, R. Calandrino and M. Schwarz. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation, International Journal of Radiation Oncology Biology Physics, 72(2) (2008) 589–596.
[12] H. Paganetti. Series in medical physics and biomedical engineering: Proton therapy physics, CRC press, Taylor & Francis group (2012).
[13] ICRP. Adult Reference Computational Phantoms, ICRP Publication 110, (2009).
[15] D. Pelowitz. MCNPX User’s Manual, Version .6.0. Los Alamos National Laboratory, Los Alamos, NM, USA (2008).
[16] D.T. Chua, J.S. Sham, W.I. Wei, W.K. Ho and G.K. Au. The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma, Cancer: Interdisciplinary International Journal of the American Cancer Society. 92(11) (2001) 2845–2855.
[17] F.M. Khan and J.P. Gibbons. Khan's the physics of radiation therapy, Lippincott Williams & Wilkins; (2014).